Advertisement Press Releases Archive - Page 187 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 06 May 2011
    Medpace Announces the Addition of Dr Jon Bruss, Medical Director, Adding Therapeutic Expertise in Infectious Disease, Antibiotics, Anti-Virals, Caccines, and Pediatric Medicines

    Medpace Announces the Addition of Dr Jon Bruss, Medical Director, Adding Therapeutic Expertise in Infectious Disease, Antibiotics, Anti-Virals, Caccines, and Pediatric Medicines

    By admin

    Medpace, Inc. today announced the addition of Jon Bruss, MD, MSPH, MBA, FAAP, FIDSA as a Medical Director with therapeutic expertise in guiding global clinical trials in infectious disease. Dr. Bruss will combine therapeutic experience with existing Medpace clinical trial teams excellence to bring innovative anti-infective drugs to market in partnership with our sponsors.

  • 06 May 2011
    Medpace Announces the Addition of Dan Weng, MD, PhD, MA as Vice President, Rest of World

    Medpace Announces the Addition of Dan Weng, MD, PhD, MA as Vice President, Rest of World

    By admin

    Medpace, Inc. today announced the addition of Dan Weng, MD, PhD, MA as Vice President, Rest of World (ROW) with responsibility for Asia, Pacific Rim, Latin America, and South Africa. Dr. Weng, an experienced clinical development professional, will be charged with driving global growth for Medpace in emerging markets. Emerging markets represent the fastest growing segment for drug development and clinical trials. The addition of Dr.Weng, along with existing Medpace clinical teams, will allow Medpace to provide deeper expertise in global development services for sponsors needing on-the-ground services in global markets.

  • 06 May 2011
  • 06 May 2011
    Medpace Announces the Addition of Brian Murphy, MD, MPH, Medical Director, Strengthening Medpace’s Therapeutic Expertise in Infectious Disease and Pediatric Drug Development

    Medpace Announces the Addition of Brian Murphy, MD, MPH, Medical Director, Strengthening Medpace’s Therapeutic Expertise in Infectious Disease and Pediatric Drug Development

    By admin

    Medpace, Inc. today announced the addition of Brian S. Murphy, MD, MPH as Medical Director with responsibility for leading clinical drug development for infectious disease and pediatric specific agents. The addition of Dr. Murphy, along with existing clinical and medical teams, will allow Medpace to provide deeper expertise in emerging therapeutic areas to bring innovative anti-infective and pediatric drugs to market in partnership with our sponsors.

  • 05 May 2011
    SCM Secures Phase II Aseptic Project

    SCM Secures Phase II Aseptic Project

    By admin

    CLINICAL trial manufacturer SCM Pharma has secured a sterile filling and packaging project with Molteni Therapeutics, an Italian-based specialty pharmaceutical company, which involves a novel drug substance being developed for the topical treatment of infected skin lesions by using the therapeutic approach known as PhotoDynamic Therapy (PDT).

  • 04 May 2011
  • 04 May 2011
    Chris Brinsmead Joins the Board of Kinapse UK

    Chris Brinsmead Joins the Board of Kinapse UK

    By admin

    The Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a Non-Executive Director of Kinapse. Chris has had a long and distinguished career in the pharmaceutical industry, notably with Astra Zeneca where he was the President of their UK business. He has also recently served as President of the Association of the British Pharmaceutical Industry (ABPI).

  • 04 May 2011
  • 04 May 2011
    Sanofi Calls CMO for Repeat C14 Project

    Sanofi Calls CMO for Repeat C14 Project

    By admin

    FRENCH pharmaceutical company sanofi-aventis has once again selected contract manufacturing organisation (CMO) SCM Pharma for the fast-tracked fill/finish of a radio-labelled product.

  • 04 May 2011
    UK CMO Unveils New Testing Services

    UK CMO Unveils New Testing Services

    By admin

    FILL/FINISH specialist SCM Pharma has launched two new testing services to complement its sterile manufacturing capabilities and reduce the risks associated with offsite testing for client projects.

«‹185186187188189›»